References
- Korea National Cancer Center. Cancer statistics. Incidence of cancer. Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html#1. Accessed Oct. 11, 2010.
- Zhou J, Zhong Y. Breast cancer immunotherapy. Cell. Mol. Immunol. 1: 247-255 (2004)
- Lee JM. It's Okay to Become Familiar Slowly: 421 of Wild Edible Greens. Hwan creative company. Seoul, Korea. p. 152 (2009)
- Choi C. Molecular biological mechanism of tumor invasion and metastasis. Life Sci. Technol. 28: 16-22 (2003)
- Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metallo-proteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol. 36: 128-137 (2003) https://doi.org/10.5483/BMBRep.2003.36.1.128
- Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS, Chen YJ. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J. Agr. Food Chem. 51: 7907-7912 (2003) https://doi.org/10.1021/jf034729d
- Moon HS, Sung SH, Chung HW, Kim SC. Expression of MT1, 2, 3-MMP in invasive cervical cancer. Korean J. Obstet. Gynecol. 49: 1240-1248 (2006)
- Kimura K, Cheng XW, Nakamura K, Inoue A, Hu L, Song H, Okumura K, Iguchi A, Murohara T, Kuzuya M. Matrix metalloproteinase- 2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2. Clin. Exp. Pharmacol. P. 37: 1096-1101 (2010) https://doi.org/10.1111/j.1440-1681.2010.05441.x
- Liabakk NB, Talbot I, Smith RA, Wikinson K, Balkwill F. Matrix metalloproteinase 2 (MMP-2) and metalloproteinases 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56: 190-196 (1996)
- Duffy MJ, Maguire TM, Hill A, McDermott E, O'iggins N. Metalloproteinases role in breast carcinogenesis, invasion, and metastasis. Breast Cancer Res. 2: 252-257 (2000) https://doi.org/10.1186/bcr65
- MacDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion, and metastasis. Cancer Metast. Rev. 14: 351-362 (1995) https://doi.org/10.1007/BF00690603
- Xu P, Wang YL, Zhu SJ, Luo SY, Piao YS, Zhuang LZ. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester. Biol. Reprod. 62: 988-994 (2000) https://doi.org/10.1095/biolreprod62.4.988
- Yoon HK, Park SM. MMP-2 and MMP-9 expressions in breast carcinomas and relationship with major prognostic factors. Korean J. Pathol. 38: 79-85 (2004)
- Lambert E, Dassé E, Haye B, Petitfrère E. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49: 187-198 (2003)
- Ulisse S, Baldini E, Toller M, Marchioni E, Giacomelli L, De Antoni E, Ferretti E, Marzullo A, Graziano FM, Trimboli P, Biordi L, Curcio F, Gulino A, Ambesi-Impiombato FS, D'Armiento M. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas. Eur. J. Cancer 42: 2631-2638 (2006) https://doi.org/10.1016/j.ejca.2006.04.017
- Jogi A, Rono B, Lund IK, Nielsen BS, Ploug M, Hoyer-Hansen G, Romer J, Lund LR. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice. PLoS One 5:e12746 (2010) https://doi.org/10.1371/journal.pone.0012746
-
Osada K, Seishima M, Kitajima Y, Yaoita H, Mori S. Decreased integrin
$\alpha$ 2, but normal response to TGF-beta in scleroderma fibroblasts. J. Dermatol. Sci. 9: 169-175 (1995) https://doi.org/10.1016/0923-1811(94)00374-N - Ko YS. Function of cell adhesion molecule (CAM) in angiogenesis. J. Korean Endocr. Soc. 16: 305-312 (2001)
- Cebe-Suarez S, Zehnder-Fjällman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis;complex partnerships. Cell. Mol. Life Sci. 63: 601-615 (2006) https://doi.org/10.1007/s00018-005-5426-3
- Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival: Modifications of the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277 (1986) https://doi.org/10.1016/0022-1759(86)90368-6
- Liotta LA, Kleinerman J, Catanawara P, Rynbrandt D. Degradation of basement membrane by murine tumor cells. J. Natl. Cancer I. 58: 1427-1431 (1977)
- Woessner JF Jr. Matrix metalloproteinase and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154 (1991)
- Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci. Signal. 1: re6 (2008) https://doi.org/10.1126/scisignal.127re6
- Crippa MP. Urokinase-type plasminogen activator. Int. J. Biochem. Cell B. 39: 690-694 (2007) https://doi.org/10.1016/j.biocel.2006.10.008
- Goh PP, Sze DM, Roufogalis BD. Molecular and cellular regulators of cancer angiogenesis. Curr. Cancer Drug Tar. 7: 743-758 (2007) https://doi.org/10.2174/156800907783220462
- Huang CS, Liao JW, Hu ML. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J. Nutr. 138: 538-543 (2008)
- Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269: 199-225 (2008) https://doi.org/10.1016/j.canlet.2008.03.009
- Springer TA. Adhesion receptors of the immune system. Nature 346: 425-434 (1990) https://doi.org/10.1038/346425a0